MARKET OVERVIEW:
The global market for Continuous Glucose Monitoring (CGM) systems is expanding rapidly, driven by factors such as technological advancements, rising diabetes prevalence, and an increasing shift toward preventive healthcare. As CGMs offer real-time glucose data, they are becoming integral for diabetes management, offering improved control and decision-making. With a market size of USD 7.04 Billion in 2024, the market is projected to reach USD 10.92 Billion by 2033, growing at a compound annual growth rate (CAGR) of 4.75% from 2025 to 2033.
STUDY ASSUMPTION YEARS:
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019
- FORECAST YEAR: 2033
CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET KEY TAKEAWAYS:
- Market Growth: The CGM systems market is projected to grow from USD 7.04 Billion in 2024 to USD 10.92 Billion by 2033, with a CAGR of 4.75%.
- Technological Innovations: Non-invasive sensors, extended wearability, and smartphone integration are driving user adoption.
- Prevalence of Diabetes: The increasing global burden of diabetes is a key factor propelling market demand.
- Regional Dominance: North America holds the largest market share of over 38.7% in 2024.
- Regulatory Approvals: The U.S. FDA approval for over-the-counter CGMs in 2023 is expanding the market’s consumer base.
MARKET GROWTH FACTORS:
Technological Advancements: There is a continuous evolution of the CGM with better sensor technology such as non-invasive sensors and smartphone connectivity, with the ultimate aim to improve usability and accuracy. These advancements will give an edge to end users, as patients and clinicians will be able to better monitor and manage glucose level interventions. Furthermore, the faster, accurate alerts of glucose levels and longer sensor lifetimes would significantly enhance the reliability of CGM devices and promote increased adoption.
Increasing Growth Case: Increasing global Diabetes prevalence stimulates the directly proportional demand for Continuous Glucose Monitoring systems. As more and more diabetics are reported-the latest epidemic of Type 2 diabetes as a result being mainly triggered by obesity is creating the need for advanced solutions in glucose monitoring, that is, CGM systems-offering continuous monitoring. Such systems allow patients to know the glucose level readings in real time to make an immediate adjustment in their lifestyle to enhance long-term health outcome and minimize complications.
A Move to Preventive Healthcare: With this trend of preventive healthcare and early detection, CGM has developed as an essential enabler in managing diabetes and overall health. These devices provide continuous monitoring of blood glucose levels, allowing for early intervention to prevent serious complications such as cardiovascular diseases. Such a trend is significant, especially in countries with high obesity rates, where timely monitoring can help curb health risks before they translate into chronic diseases.
Request Sample For PDF Report: https://www.imarcgroup.com/continuous-glucose-monitoring-systems-market/requestsample
Market Segmentation:
Analysis by Component:
- Sensors
- Transmitters and Receivers
- Integrated Insulin Pumps
Analysis by Demographics:
- Child Population (≤14 years)
- Adult Population (>14 years)
Analysis by End User:
- Clinics and Diagnostics Centers
- ICUs
- Home Healthcare
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Key Players:
- A. Menarini Diagnostics S.r.l.
- Abbott Laboratories
- DexCom Inc.
- F. Hoffmann-La Roche AG
- Glysens Incorporated
- LifeScan Inc. (Johnson & Johnson)
- Medtronic PLC
- Medtrum Technologies Inc.
- Nemaura Medical Inc.
- Novo Nordisk A/S
- Senseonics Holdings Inc.
- Waveform Technologies Inc.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.